EUVIMEDOpdag EUVIMED
Multizentrische StudieOpen access · CC BY-NC-ND 4.0

Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome

Domenico Plantone iD, Eleonora Sabatelli, Sara Locci, Mariano Marrodan iD, Sini M Laakso, Farrah J Mateen iD, Amalia Feresiadou, Tom Buelens, Assunta Bianco iD, Marcela P Fiol iD, Jorge Correale iD, Pentti Tienari iD and 3 more

European Journal of Neurology · 2023

DOI: 10.1111/ene.15939 ↗

At a glance

Multizentrische Studie in European Journal of Neurology, 2023. Written by Domenico Plantone and 14 co-authors. Institution: Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy. Major MEDLINE topics: Multiple Sclerosis, Susac Syndrome. Cited 5 times so far (Crossref); 29 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and purpose Serum levels of neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) are promising neuro‐axonal damage and astrocytic activation biomarkers. Susac syndrome (SS) is an increasingly recognized neurological condition and biomarkers that can help assess and monitor disease evolution are highly needed for the adequate management of these patients. sNfL and sGFAP levels were evaluated in patients with SS and their clinical relevance in the relapse and remission phase of the disease was assessed.

Methods

As part of a multicentre study that enrolled patients diagnosed with SS from six international centres, sNfL and sGFAP levels were assessed in 22 SS patients (nine during a relapse and 13 in remission) and 59 age‐ and sex‐matched healthy controls using SimoaTM assay Neurology 2‐Plex B Kit.

Results

Serum NfL levels were higher than those of healthy controls ( p < 0.001) in SS patients and in both subgroups of patients in relapse and in remission ( p < 0.001 for both), with significantly higher levels in relapse than in remission ( p = 0.008). sNfL levels showed a negative correlation with time from the last relapse ( r = −0.663; p = 0.001). sGFAP levels were slightly higher in the whole group of patients than in healthy controls ( p = 0.046) and were more pronounced in relapse than in remission ( p = 0.013).

Conclusion

In SS patients, both sNFL and sGFAP levels increased compared with healthy controls. Both biomarkers had higher levels during clinical relapse and much lower levels in remission. sNFL was shown to be time sensitive to clinical changes and can be useful to monitor neuro‐axonal damage in SS.

Subjects

MeSH terms (MEDLINE)

Multiple SclerosisSusac SyndromeHumansBiomarkersGlial Fibrillary Acidic ProteinIntermediate FilamentsNeurofilament ProteinsRecurrence

Author keywords

biomarkersinflammationneuro-ophthalmologyneuro-otology

Substances

BiomarkersGlial Fibrillary Acidic ProteinNeurofilament Proteinsneurofilament protein L

Authors and institutions

  • Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Neurology Unit, Fondazione Policlinico Universitario 'A.Gemelli' IRCCS, Rome, Italy.
  • Neurology Department, Fleni, Buenos Aires, Argentina.
  • Clinical Neurosciences, Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.

ORCID profiles: Domenico Plantone, Mariano Marrodan, Farrah J Mateen, Assunta Bianco, Marcela P Fiol, Jorge Correale, Pentti Tienari, Raffaele Iorio

Cite

APA

Plantone, D., Sabatelli, E., Locci, S., Marrodan, M., Laakso, S. M., Mateen, F. J., Feresiadou, A., Buelens, T., Bianco, A., Fiol, M. P., Correale, J., Tienari, P., Calabresi, P., De Stefano, N., & Iorio, R. (2023). Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome. European Journal of Neurology. https://doi.org/10.1111/ene.15939

Vancouver

Plantone D, Sabatelli E, Locci S, Marrodan M, Laakso SM, Mateen FJ, et al. Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome. European Journal of Neurology. 2023. doi:10.1111/ene.15939

BibTeX
@article{Plantone2023,
  author = {Plantone, Domenico and Sabatelli, Eleonora and Locci, Sara and Marrodan, Mariano and Laakso, Sini M and Mateen, Farrah J and Feresiadou, Amalia and Buelens, Tom and Bianco, Assunta and Fiol, Marcela P and Correale, Jorge and Tienari, Pentti and Calabresi, Paolo and De Stefano, Nicola and Iorio, Raffaele},
  title = {Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome},
  journal = {European Journal of Neurology},
  year = {2023},
  doi = {10.1111/ene.15939}
}
Start for free →